Literature DB >> 15293900

[Epidemiological evaluation of a possible outbreak in and nearby Tokat province].

Ayşegül Gözalan1, Levent Akin, Jean-Marc Rolain, Fatih Sua Tapar, Ozgür Oncül, Hiroshi Yoshikura, Herve Zeller, Didier Raoult, Berrin Esen.   

Abstract

Between the dates of May 4th-August 6th 2002, 46 cases were detected with abdominal pain nausea, vomiting, arthralgia/myalgia, headache, fever, diarrhea and rash, in the middle Blacksea and north inner Anatolia regions. Their laboratory findings yielded elevated levels of liver enzymes (AST, ALT, LDH), leucopenia and thrombocytopenia. As the infection was treated easily with tetracyclines, clinical diagnosis was considered to be rickettsiosis or ehrlichiosis. Serum and blood samples obtained from some of the patients were tested against Rickettsia, Ehrlichia, Leptospira and Coxiella, in the national and international laboratories. Samples from 19 patients were sent to National Reference Centre and WHO Collaborating Centre for Rickettsial Reference and Research Laboratory, France, and 7 of them were reported as acute Q fever while 8 of them were reported as passed Q fever (QF) cases. In May 2003, new cases with similar symptoms have been reported from the same regions, with different epidemiologic and serologic findings (tick exposure history was higher, response to tetracycline was lower, C. burnetii antibodies were negative), indicating a viral etiology. The samples of these patients have been sent to National Reference Centre and WHO Collaborating Centre for Arboviruses and Viral Heamorrhagic Fevers, France, and the initial reports were marked as Crimean Congo hemorrhagic fever virus (CCHFV). Then the serum samples of previous 26 patients which were stored in National Serum Bank have been retrospectively investigated for viral aetiology in the same center, and 17 of them have been found positive for CCHFV IgM antibodies. Four of these patients were diagnosed as acute QF in 2002, one was passed QF, 2 were negative for QF and 10 were patients not investigated for QF. As a result, the detection of the both infections together in the same area shows the essential need for further epidemiological investigations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15293900

Source DB:  PubMed          Journal:  Mikrobiyol Bul        ISSN: 0374-9096            Impact factor:   0.622


  5 in total

1.  Seroprevalence of Q fever in a district located in the west Black Sea region of Turkey.

Authors:  A Gozalan; J M Rolain; M Ertek; E Angelakis; N Coplu; E A Basbulut; B B Korhasan; B Esen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-03-02       Impact factor: 3.267

2.  Crimean-Congo hemorrhagic fever virus: genetic analysis and tick survey in Turkey.

Authors:  Sukru Tonbak; Munir Aktas; Kursat Altay; Ahmet K Azkur; Ahmet Kalkan; Yusuf Bolat; Nazir Dumanli; Aykut Ozdarendeli
Journal:  J Clin Microbiol       Date:  2006-11       Impact factor: 5.948

Review 3.  Crimean-Congo hemorrhagic fever in Iran.

Authors:  Maryam Keshtkar-Jahromi; Mohammad M Sajadi; Hossein Ansari; Masoud Mardani; Kourosh Holakouie-Naieni
Journal:  Antiviral Res       Date:  2013-07-18       Impact factor: 5.970

4.  Genetic analysis and epidemiology of Crimean Congo Hemorrhagic fever viruses in Baluchistan province of Pakistan.

Authors:  Muhammad Masroor Alam; Adnan Khurshid; Salmaan Sharif; Shahzad Shaukat; Muhammad Suleman Rana; Mehar Angez; Syed Sohail Zahoor Zaidi
Journal:  BMC Infect Dis       Date:  2013-05-04       Impact factor: 3.090

5.  Crimean-Congo hemorrhagic fever virus in high-risk population, Turkey.

Authors:  Turabi Gunes; Aynur Engin; Omer Poyraz; Nazif Elaldi; Safak Kaya; Ilyas Dokmetas; Mehmet Bakir; Ziynet Cinar
Journal:  Emerg Infect Dis       Date:  2009-03       Impact factor: 6.883

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.